COCRYSTAL PHARMA, INC. Income (Loss) from Equity Method Investments
COCRYSTAL PHARMA, INC. (COCP) reported Income (Loss) from Equity Method Investments of -$42.68 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2013-04-01.
Discontinued › Income Statement › Other Income
us-gaap:IncomeLossFromEquityMethodInvestments · last filed 2013-04-01
- COCRYSTAL PHARMA, INC. income (loss) from equity method investments for the quarter ending 2011-03-31 was -$6.59K.
- COCRYSTAL PHARMA, INC. income (loss) from equity method investments for fiscal 2011 was -$42.68K, a 177.17% decline from fiscal 2010.
- COCRYSTAL PHARMA, INC. income (loss) from equity method investments for fiscal 2010 was $55.30K.
| Period end | Income (Loss) from Equity Method Investments 3 month | Income (Loss) from Equity Method Investments 12 month |
|---|---|---|
| 2011-12-31 | -$42.68K 10-K · filed 2013-04-01 | |
| 2011-03-31 | -$6.59K 10-Q/A · filed 2012-10-02 | |
| 2010-12-31 | $55.30K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |